Correlia Biosystems

Closed

Next-gen blood testing to provide 1000x more data to pharma companies

Berkeley, United States · Founded 2013 · $7.0M raised

Employees
11–50
Founded
2013
Total Funding
$7.0M
Last Round
$7.0M Series ADec 2020
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules. Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.

Summary

Correlia Biosystems is a Biotech company based in Berkeley, United States, founded in 2013. It has raised $7.0M in total across 2 rounds, most recently a $7.0M Series A round in Dec 2020. Investors include NeoTribe Ventures, Y Combinator and Cota Capital.

Funding History

Series ASeries ADec 2020
$7.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Correlia Biosystems on Indexed.vc
<a href="https://indexed.vc/companies/correlia-biosystems"><img src="https://indexed.vc/api/badge/company/correlia-biosystems" alt="Correlia Biosystems on Indexed.vc" width="260" height="76" /></a>